130 related articles for article (PubMed ID: 28817570)
1. Increased hepatotoxicity among HIV-infected adults co-infected with Schistosoma mansoni in Tanzania: A cross-sectional study.
Marti AI; Colombe S; Masikini PJ; Kalluvya SE; Smart LR; Wajanga BM; Jaka H; Peck RN; Downs JA
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005867. PubMed ID: 28817570
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and intensity of
Mazigo HD; Kirway L; Ambrose EA
BMJ Open; 2019 Jul; 9(7):e029749. PubMed ID: 31345980
[TBL] [Abstract][Full Text] [Related]
3. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
4. Periportal fibrosis, liver and spleen sizes among S. mansoni mono or co-infected individuals with human immunodeficiency virus-1 in fishing villages along Lake Victoria shores, North-Western, Tanzania.
Mazigo HD; Dunne DW; Morona D; Lutufyo TE; Kinung'hi SM; Kaatano G; Nuwaha F
Parasit Vectors; 2015 May; 8():260. PubMed ID: 25948238
[TBL] [Abstract][Full Text] [Related]
5. Co-infection with Schistosoma mansoni and Human Immunodeficiency Virus-1 (HIV-1) among residents of fishing villages of north-western Tanzania.
Mazigo HD; Dunne DW; Wilson S; Kinung'hi SM; Pinot de Moira A; Jones FM; Morona D; Nuwaha F
Parasit Vectors; 2014 Dec; 7():587. PubMed ID: 25511298
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection.
Aceti A; Pasquazzi C; Zechini B; De Bac C;
J Acquir Immune Defic Syndr; 2002 Jan; 29(1):41-8. PubMed ID: 11782588
[TBL] [Abstract][Full Text] [Related]
7. Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: A nested case-control study.
Downs JA; Dupnik KM; van Dam GJ; Urassa M; Lutonja P; Kornelis D; de Dood CJ; Hoekstra P; Kanjala C; Isingo R; Peck RN; Lee MH; Corstjens PLAM; Todd J; Changalucha JM; Johnson WD; Fitzgerald DW
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005968. PubMed ID: 28945756
[TBL] [Abstract][Full Text] [Related]
8. Schistosomiasis and HIV-1 viral load in HIV-infected outpatients with immunological failure in Tanzania: a case-control study.
Masikini P; Colombe S; Marti A; Desderius B; de Dood CJ; Corstjens PLAM; van Dam GJ; Seugendo M; Kalluvya S; Downs JA
BMC Infect Dis; 2019 Mar; 19(1):249. PubMed ID: 30866830
[TBL] [Abstract][Full Text] [Related]
9. Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.
Darge T; Babusha A; Chilo D; Dukessa A; Teferi S
Sci Rep; 2024 Apr; 14(1):8473. PubMed ID: 38605149
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Alanine Aminotransferase Elevations in a Prospective Cohort of HIV-Infected Tanzanian Adults Initiating Antiretroviral Therapy.
Mugusi SF; Sando D; Mugusi FM; Hawkins C; Aboud S; Fawzi WW; Sudfeld CR
J Int Assoc Provid AIDS Care; 2019; 18():2325958219884939. PubMed ID: 31665968
[TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.
Ngongondo M; Miyahara S; Hughes MD; Sun X; Bisson GP; Gupta A; Kumwenda J; Lavenberg JA; Torres TS; Nyirenda M; Kidonge KK; Hosseinipour MC;
J Acquir Immune Defic Syndr; 2018 May; 78(1):54-61. PubMed ID: 29406428
[TBL] [Abstract][Full Text] [Related]
12. Association of schistosome infection with adiposity in Tanzania.
Pham K; PrayGod G; Faurholt-Jepsen D; Olsen MF; Kavishe B; Kitilya B; Corstjens PLAM; de Dood CJ; Friis H; Filteau S; Downs JA; Peck RN
Front Public Health; 2022; 10():1008101. PubMed ID: 36684996
[TBL] [Abstract][Full Text] [Related]
13. The burden, pattern and factors that contribute to periportal fibrosis in HIV-infected patients in an
Ocama P; Opio KC; Seremba E; Ajal P; Apica BS; Aginya EO
Afr Health Sci; 2017 Jun; 17(2):301-307. PubMed ID: 29062323
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania.
Hawkins C; Christian B; Ye J; Nagu T; Aris E; Chalamilla G; Spiegelman D; Mugusi F; Mehta S; Fawzi W
AIDS; 2013 Mar; 27(6):919-927. PubMed ID: 23196935
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda.
Yegorov S; Galiwango RM; Good SV; Mpendo J; Tannich E; Boggild AK; Kiwanuka N; Bagaya BS; Kaul R
BMC Infect Dis; 2018 Nov; 18(1):586. PubMed ID: 30453907
[TBL] [Abstract][Full Text] [Related]
16. Co-infection of Schistosoma mansoni/hepatitis C virus and their associated factors among adult individuals living in fishing villages, north-western Tanzania.
Mazigo HD; Kepha S; Kaatano GM; Kinung'hi SM
BMC Infect Dis; 2017 Oct; 17(1):668. PubMed ID: 29017483
[TBL] [Abstract][Full Text] [Related]
17. Status of selected biochemical and coagulation profiles and platelet count in malaria and malaria-Schistosoma mansoni co-infection among patients attending at Dembiya selected Health Institutions, Northwest Ethiopia.
Abebe W; Asmare Z; Wondmagegn A; Awoke M; Adgo A; Derso A; Lemma W
Sci Rep; 2024 Mar; 14(1):6135. PubMed ID: 38480873
[TBL] [Abstract][Full Text] [Related]
18. Contribution of Schistosoma mansoni to systemic inflammation and microbial translocation among people with HIV in Zambia.
Furch BD; Mwakamui S; Sianongo S; Zyambo K; Heimburger DC; Koethe JR; Kelly P
Trans R Soc Trop Med Hyg; 2022 Feb; 116(2):179-186. PubMed ID: 34263318
[TBL] [Abstract][Full Text] [Related]
19. Infection with Schistosoma mansoni has an Effect on Quality of Life, but not on Physical Fitness in Schoolchildren in Mwanza Region, North-Western Tanzania: A Cross-Sectional Study.
Kinung'hi S; Magnussen P; Kaatano G; Olsen A
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005257. PubMed ID: 28027317
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapy.
Chihrin S; Antoniou T; Raboud J; Shen S; Govan V; Fletcher D; Rachlis A; Kovacs C; Crouzat F; Tilley D; Chang B; Saskin R; Loutfy MR
AIDS Patient Care STDS; 2007 Jul; 21(7):469-78. PubMed ID: 17651028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
